Esomeprazole and omeprazole could improve the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) bringing about increased adverse effects including drowsiness, although the clinical relevance is minimal in many individuals – keep track of the affected person for adverse effects (e.If affected individual are not able to resume